News from armagen technologies, inc

Jan 03, 2013, 19:14 ET

ArmaGen Technologies, Inc. Hires Biotech Executive as CEO

ArmaGen Technologies, Inc., a leader in the delivery of biotherapeutics targeting the central nervous system (CNS), today announced James Callaway,...

Nov 29, 2012, 19:39 ET

ArmaGen Technologies, Inc. Announces $17 Million Series A Financing

 ArmaGen Technologies, Inc. today announced the closing of a $17 million Series A financing to support the development of brain-penetrating...

Jul 16, 2010, 18:32 ET

ArmaGen® Re-engineers Erythropoietin for Brain Penetration

Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge